Lumiliximab Biosimilar - Anti-CD23 Antibody - BSA and Azide free (A338516)

Lumiliximab Biosimilar - Anti-CD23 Antibody - BSA and Azide free

Recombinant chimeric monoclonal antibody to CD23 for use as a research grade Lumiliximab biosimilar.

ELISA, Flow Cytometry, Functional Studies, in vivo Research

Human

Chimeric

Monoclonal

IgG1

The purity of this Biosimilar is >95%, as determined by SDS-PAGE.

Liquid

Supplied in 0.01M Phosphate Buffered Saline, pH 7.4.

Shipped at 4°C. Upon delivery store at 4°C for short-term use (1-2 weeks) or aliquot and store at -20°C for long-term use (up to 12 months).

BLAST-2, C-type lectin domain family 4 member J, CD23A, CLEC4J, Fc-epsilon-RII, FCE2, FCER2, IGEBF, Immunoglobulin E-binding factor, Low affinity immunoglobulin epsilon Fc receptor, Lymphocyte IgE receptor

This product is for research use only. It is not intended for diagnostic or therapeutic use.